blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2068881

EP2068881 - METHOD OF TREATING THERMOREGULATORY DISFUNCTION WITH PAROXETINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.06.2019
Database last updated on 21.05.2024
FormerThe patent has been granted
Status updated on  20.07.2018
FormerGrant of patent is intended
Status updated on  11.03.2018
FormerExamination is in progress
Status updated on  10.03.2017
Most recent event   Tooltip28.06.2019No opposition filed within time limitpublished on 31.07.2019  [2019/31]
Applicant(s)For all designated states
Sebela International Limited
H.P. House
21 Laffan Street
Hamilton HM09 / BM
[2017/13]
Former [2009/25]For all designated states
Noven Therapeutics, LLC
11960 S.W. 144th Street
Miami FL 33186 / US
Inventor(s)01 / RICHARDS, Patricia, Allison, Tewes
22 Ave. Port Imperial,Apt. 114
West New York, NJ 07093 / US
 [2009/30]
Former [2009/25]01 / RICHARDS, Patricia, Allison, Tewes
148 Edgemont Road
New York, NY 10583 / US
Representative(s)Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2018/34]
Former [2009/25]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date07810919.631.07.2007
[2009/25]
WO2007US17062
Priority number, dateUS2006049958604.08.2006         Original published format: US 499586
[2009/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008019010
Date:14.02.2008
Language:EN
[2008/07]
Type: A2 Application without search report 
No.:EP2068881
Date:17.06.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 14.02.2008 takes the place of the publication of the European patent application.
[2009/25]
Type: B1 Patent specification 
No.:EP2068881
Date:22.08.2018
Language:EN
[2018/34]
Search report(s)International search report - published on:US24.12.2008
(Supplementary) European search report - dispatched on:EP31.08.2009
ClassificationIPC:A61K31/4525, A61P5/24, A61P15/12
[2009/39]
CPC:
A61K31/4525 (EP,US); A61K31/445 (KR,NO); A61K31/36 (NO);
A61P15/12 (EP,US); A61P5/24 (EP,US)
Former IPC [2009/25]A61K31/54, A61K31/33
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/34]
Former [2009/25]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL18.02.2009
BA18.02.2009
HR18.02.2009
MK18.02.2009
RS18.02.2009
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON THERMOREGULATORISCHER DYSFUNKTION MIT PAROXETIN[2009/25]
English:METHOD OF TREATING THERMOREGULATORY DISFUNCTION WITH PAROXETINE[2009/25]
French:MÉTHODE POUR TRAITER UN DYSFONCTIONNEMENT DE THERMORÉGULATION AVEC DE LA PAROXÉTINE[2009/25]
Entry into regional phase18.02.2009National basic fee paid 
18.02.2009Search fee paid 
18.02.2009Designation fee(s) paid 
18.02.2009Examination fee paid 
Examination procedure18.02.2009Examination requested  [2009/25]
26.11.2009Amendment by applicant (claims and/or description)
20.10.2011Despatch of a communication from the examining division (Time limit: M06)
30.04.2012Reply to a communication from the examining division
14.03.2014Despatch of a communication from the examining division (Time limit: M04)
10.07.2014Reply to a communication from the examining division
28.02.2017Despatch of a communication from the examining division (Time limit: M04)
28.06.2017Reply to a communication from the examining division
19.10.2017Despatch of a communication from the examining division (Time limit: M04)
08.01.2018Reply to a communication from the examining division
12.03.2018Communication of intention to grant the patent
28.06.2018Fee for grant paid
28.06.2018Fee for publishing/printing paid
28.06.2018Receipt of the translation of the claim(s)
Divisional application(s)EP13190594.5  / EP2719385
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.10.2011
Opposition(s)23.05.2019No opposition filed within time limit [2019/31]
Fees paidRenewal fee
08.07.2009Renewal fee patent year 03
08.07.2010Renewal fee patent year 04
16.07.2011Renewal fee patent year 05
10.07.2012Renewal fee patent year 06
08.07.2013Renewal fee patent year 07
08.07.2014Renewal fee patent year 08
09.07.2015Renewal fee patent year 09
11.07.2016Renewal fee patent year 10
12.07.2017Renewal fee patent year 11
11.07.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2007043057  (YISSUM RES DEV CO [IL], et al) [XP] 1-12 * paragraph [0051]; claims 23,37 *;
 [XY]  - LOPRINZI ET AL, "Centrally active nonhormonal hot flash therapies", AMERICAN JOURNAL OF MEDICINE,, (20051201), vol. 118, no. 12, ISSN 0002-9343, pages 1409 - 1410, XP005788028 [X] 1-5,11,12 * page 121S, column 1, paragraph 2; table 1 * [Y] 1-12

DOI:   http://dx.doi.org/10.1016/j.amjmed.2005.10.021
 [XY]  - LOPRINZI CHARLES L; BARTON DEBRA L; CARPENTER LISA A; SLOAN JEFF A; NOVOTNY PAUL J; GETTMAN MATTHEW T; CHRISTENSEN BRADLEY J, "Pilot evaluation of paroxetine for treating hot flashes in men.", MAYO CLINIC PROCEEDINGS, United States, (200410), vol. 79, no. 10, pages 1247 - 1251, XP002540880 [X] 1-5,11,12 * page 1247, column 2, paragraph 7 * * page 1248, column 1, paragraph 4 * * page 1249, column 1, paragraph 4 * * page 1250, column 2, paragraph 2 * [Y] 1-12

DOI:   http://dx.doi.org/10.4065/79.10.1247
 [Y]  - HARADA KEN-ICHI, "Paroxetine-induced excessive yawning.", PSYCHIATRY AND CLINICAL NEUROSCIENCES, Australia, (20060314), vol. 60, no. 2, pages 260 - 260, XP002540881 [Y] 1-12 * page 260, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1111/j.1440-1819.2006.01497.x
 [T]  - "Paxil (Seroxat) - Translation of the manufacturer's insert", (20010321), pages 1 - 2, URL: http://web.archive.org/web/20010419173616/http://www.antiaging-systems.com/apruses/paxil.htm, (20090817), XP002541701 [T] 1-12 * page 1, paragraph 8 *
International search[Y]US6369051  (JENKINS SIMON NICHOLAS [US]);
 [X]  - STEARNS V., "A Pilot Trial Assessing the Efficacy of Paroxetine hydrochloride in Controlling Hot Flashes in Breast Cancer Survivors", ANNALS OF ONCOLOGY, (2000), pages 17 - 22, XP008103197
 [X]  - STEARNS V., "Paroxetine is an Effective Treatment for Hot Flashes", JOURNAL OF CLINICAL ONCOLOGY, (200510), vol. 23, pages 6919 - 6930, XP008103198
Examination   - STEARNS VERED ET AL, "Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial.", JAMA (JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION), (20030604), vol. 289, no. 21, ISSN 0098-7484, pages 2827 - 2834
by applicantUS4007196
 US4721723
 US4861893
 US5039803
 US5470846
 US5672612
 US5872132
 US5900423
 WO9944601
 US5955475
 US5985322
 US6063927
 US6080759
 US6113944
 US6133277
 US6172233
 US2001023253
 US6326496
 US2002035130
 US6369051
 US2002042432
 US2002090394
 US6433179
 US6436956
 US6440459
 US2002193406
 US6498184
 US6541637
 US6638948
 US6645523
 US6660298
 US6686473
 US6699882
 US6716985
 US2004092519
 US2004143120
 US2004152710
 US6881845
 US6900327
 US2005130987
 US6956121
 US2006020014
    - TROTT et al., "An Open Tial ofSertraline for Menopausal Hot Flushes: Potential Involvement of Serotonin in Vasomotor Instability", Del. Med. Jrl, (19970900), vol. 69, no. 9, pages 481 - 482
    - ROTH et al., "SERTRALINE RELIEVES HOT FLASHES SECONDARY TO MEDICAL CASTRATION AS TREATMENT OF ADVANCED PROSTATE CANCER", Psycho-Oncology, (19980000), vol. 7, doi:doi:10.1002/(SICI)1099-1611(199803/04)7:2<129::AID-PON294>3.0.CO;2-T, pages 129 - 132, XP000997877

DOI:   http://dx.doi.org/10.1002/(SICI)1099-1611(199803/04)7:2<129::AID-PON294>3.0.CO;2-T
    - STEAMS et al., "A pilot trial assessing the efficacy ofparoxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors", Annals of Oncology, (20000000), vol. 11, pages 17 - 22
    - STEAMS et al., "Paroxetine Controlled Release in the Treatment of Menopausal Hot Flashes", J. Am. Med. Assoc., (20030000), vol. 289, no. 21, doi:doi:10.1001/jama.289.21.2827, pages 2827 - 2834, XP055106259

DOI:   http://dx.doi.org/10.1001/jama.289.21.2827
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.